PlGF knockdown attenuates hypoxia-induced stimulation of cell proliferation and glycolysis of lung adenocarcinoma through inhibiting Wnt/β-catenin pathway

by Wei Zhang, Yanwei Zhang, Wensheng Zhou, Fangfei Qian, Minjuan Hu, Ya Chen, Jun Lu, Yuqing Lou, Baohui Han
Published 2021-01-01

Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC

by Ya Chen, Zhengyu Yang, Yanan Wang, Minjuan Hu, Bo Zhang, Yanwei Zhang, Fangfei Qian, Wei Zhang, Baohui Han
Published 2021-04-01

Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50%: Results of a Retrospective Study

by Ya Chen, Yanan Wang, Zhengyu Yang, Minjuan Hu, Yanwei Zhang, Fangfei Qian, Wei Zhang, Bo Zhang, Baohui Han
Published 2021-06-01

Comparative Study of Pulmonary Combined Large-Cell Neuroendocrine Carcinoma and Combined Small-Cell Carcinoma in Surgically Resected High-Grade Neuroendocrine Tumors of the Lung

by Yanan Wang, Fangfei Qian, Ya Chen, Zhengyu Yang, Minjuan Hu, Jun Lu, Yanwei Zhang, Wei Zhang, Lei Cheng, Baohui Han
Published 2021-09-01